Esplenectomía en hematología : ¿sigue teniendo lugar en el manejo de la trombocitopenia inmune primaria?

Carmen Rosales; Virginia Abello

doi:10.51643/22562915.309

Splenectomy in hematology : does it still have a place in the management of primary immune thrombocytopenia?

Esplenectomía en hematología : ¿sigue teniendo lugar en el manejo de la trombocitopenia inmune primaria?

Published 2012-09-01

Open | Download

PDF (Spanish) FLIP

How to Cite

1.

Rosales C, Abello V. Splenectomy in hematology : does it still have a place in the management of primary immune thrombocytopenia?. Rev. colomb. hematol. oncol. [Internet]. 2012 Sep. 1 [cited 2025 Dec. 5];1(3):13-4. https://doi.org/10.51643/22562915.309

Download Citation

Citations

Citations in Crossref

Citations in Scopus

Google Sholar Citation

Issue

Vol. 1 No. 3 (2012): Septiembre

Section

Editorial

How to Cite

1.

Rosales C, Abello V. Splenectomy in hematology : does it still have a place in the management of primary immune thrombocytopenia?. Rev. colomb. hematol. oncol. [Internet]. 2012 Sep. 1 [cited 2025 Dec. 5];1(3):13-4. https://doi.org/10.51643/22562915.309

DOI

https://doi.org/10.51643/22562915.309

Dimensions

PlumX

license

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Carmen Rosales

Clínica de Marly ; Fundación Universitaria de Ciencias de la Salud (FUCS)

Virginia Abello

Clínica de Marly ; Fundación Universitaria de Ciencias de la Salud (FUCS)

Show authors biography

Carmen Rosales,

Departamento de Hematología y Unidad de Trasplante de Médula Ósea, Clínica de Marly (Bogotá, Colombia). Hospital de San José, Fundación Universitaria de Ciencias de la Salud (FUCS) (Bogotá, Colombia).

Virginia Abello,

Departamento de Hematología y Unidad de Trasplante de Médula Ósea, Clínica de Marly (Bogotá, Colombia). Hospital de San José, Fundación Universitaria de Ciencias de la Salud (FUCS) (Bogotá, Colombia).

Article visits 147 | PDF visits 146

Downloads

Download data is not yet available.

Baccarani U, Terrosu G, Donini A, Zaja F, Bresadola F, Baccarani M. Splenectomy in hematology. Current practice and new perspectives. Haematologica. 1999;84(5):431-6.
Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004;104(9):2623-34.
Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, et al. Eficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008;371(9610):395-403.
Bussel JB, Kuter DJ, Pullarkat V, Lyons RM, Guo M, Nichol JL. Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. Blood. 2009;113(10):2161-71.
Bussel JB, Provan D, Shamsi T, Cheng G, Psaila B, Kovaleva L, et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet. 2009;373(9664):641-8.
Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med. 2007;146(1):25-33.